Literature DB >> 24632553

High neuropilin 1 expression was associated with angiogenesis and poor overall survival in resected pancreatic ductal adenocarcinoma.

Qiwen Ben1, Jianming Zheng, Jian Fei, Wei An, Ping Li, Zhaoshen Li, Yaozong Yuan.   

Abstract

OBJECTIVES: Neuropilin 1 (NRP-1) appears to promote angiogenesis by acting as a coreceptor with vascular endothelial growth factor receptor. We correlated NRP-1 expression with microvessel density (MVD) and overall survival (OS) in human pancreatic ductal adenocarcinomas (PDACs).
METHODS: Neuropilin 1 expression was graded semiquantitatively using immunohistochemistry in patients with resected PDAC. Moreover, MVD was determined with an anti-CD31 antibody staining. Expression of NRP-1 was correlated with MVD and clinicopathologic features in patients with PDAC. Overall survival effects of NRP-1 expression were evaluated by multivariate Cox regression and Kaplan-Meier analyses.
RESULTS: High NRP-1 expression was associated with advanced Union for International Cancer Control stage (P = 0.046), T stage (P = 0.031), and lymph node invasion (P = 0.045). Microvessel density was significantly higher in the tumors with high NRP-1 expression than that in the tumors with low NRP-1 expression (mean, 13.9 [SD, 9.1] vs 10.2 [SD, 7.2] per high-power field; P = 0.001). The multivariate Cox regression analysis demonstrated that high NRP-1 expression was independently associated with reduced OS (hazard ratio, 2.10; 95% confidence interval, 1.19-3.70).
CONCLUSIONS: Neuropilin 1 is highly expressed in PDACs, and high expression of NRP-1 is significantly correlated with angiogenesis, advanced tumor-node-metastasis stage, p T stage, node invasion, and poor postoperative OS.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24632553     DOI: 10.1097/MPA.0000000000000117

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  13 in total

1.  Targeting the Tumor Core: Hypoxia-Responsive Nanoparticles for the Delivery of Chemotherapy to Pancreatic Tumors.

Authors:  Matthew I Confeld; Babak Mamnoon; Li Feng; Heather Jensen-Smith; Priyanka Ray; James Froberg; Jiha Kim; Michael A Hollingsworth; Mohiuddin Quadir; Yongki Choi; Sanku Mallik
Journal:  Mol Pharm       Date:  2020-07-22       Impact factor: 4.939

2.  Circulating soluble neuropilin-1 in patients with early cervical cancer and cervical intraepithelial neoplasia can be used as a valuable diagnostic biomarker.

Authors:  Shouhua Yang; Henghui Cheng; Zaiju Huang; Xiaoling Wang; Yinglu Wan; Jing Cai; Zehua Wang
Journal:  Dis Markers       Date:  2015-03-19       Impact factor: 3.434

3.  Prognostic Evaluation of Vimentin Expression in Correlation with Ki67 and CD44 in Surgically Resected Pancreatic Ductal Adenocarcinoma.

Authors:  Despoina Myoteri; Dionysios Dellaportas; Panagis M Lykoudis; Alexandros Apostolopoulos; Athanasios Marinis; Adamantia Zizi-Sermpetzoglou
Journal:  Gastroenterol Res Pract       Date:  2017-03-22       Impact factor: 2.260

4.  VEGF receptor-2/neuropilin 1 trans-complex formation between endothelial and tumor cells is an independent predictor of pancreatic cancer survival.

Authors:  Eric Morin; Elin Sjöberg; Vegard Tjomsland; Chiara Testini; Cecilia Lindskog; Oskar Franklin; Malin Sund; Daniel Öhlund; Sara Kiflemariam; Tobias Sjöblom; Lena Claesson-Welsh
Journal:  J Pathol       Date:  2018-09-04       Impact factor: 7.996

Review 5.  Jack of many trades: Multifaceted role of neuropilins in pancreatic cancer.

Authors:  Pratiek N Matkar; Eric D Jong; Ramya Ariyagunarajah; Gerald J Prud'homme; Krishna K Singh; Howard Leong-Poi
Journal:  Cancer Med       Date:  2018-09-14       Impact factor: 4.452

Review 6.  Neuropilins Controlling Cancer Therapy Responsiveness.

Authors:  Virginia Napolitano; Luca Tamagnone
Journal:  Int J Mol Sci       Date:  2019-04-25       Impact factor: 5.923

7.  The miR-141/neuropilin-1 axis is associated with the clinicopathology and contributes to the growth and metastasis of pancreatic cancer.

Authors:  Lixin Ma; Bo Zhai; Huaqiang Zhu; Weidong Li; Wenjing Jiang; Liwang Lei; Shujun Zhang; Haiquan Qiao; Xian Jiang; Xueying Sun
Journal:  Cancer Cell Int       Date:  2019-09-27       Impact factor: 5.722

Review 8.  Neuropilin-1: A Key Protein to Consider in the Progression of Pediatric Brain Tumors.

Authors:  Manon Douyère; Pascal Chastagner; Cédric Boura
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

9.  Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects.

Authors:  Hannes Borchardt; Alexander Schulz; Kaustubh Datta; Michael H Muders; Achim Aigner
Journal:  Sci Rep       Date:  2019-10-29       Impact factor: 4.379

10.  Perivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinoma.

Authors:  Eric Morin; Cecilia Lindskog; Martin Johansson; Lars Egevad; Per Sandström; Ulrika Harmenberg; Lena Claesson-Welsh; Elin Sjöberg
Journal:  J Pathol       Date:  2020-01-29       Impact factor: 7.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.